BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE
Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY
Bristol-myers Squibb Company BMY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Bristol-myers Squibb Company BMY
Bristol Myers: FDA Accepts SBLA For Opdivo Plus Yervoy, Opdivo Plus Chemotherapy In ESCC Patients
(RTTNews) - Bristol Myers Squibb (BMY) announced Monday that the U.S. Food and Drug Administration has accepted the supplemental Biologics License Applications or sBLA for both Opdivo (nivolumab) in combination with Yervoy (ipilimumab) and Opdivo in combin
Announcement as on 27 September 2021
Bristol Myers Reports FDA Priority Review For Relatlimab And Nivolumab Combination
(RTTNews) - Bristol Myers Squibb (BMY) said FDA has accepted for priority review the Biologics License Application for relatlimab and nivolumab fixed-dose combination in the treatment of adult and pediatric patients with unresectable or metastatic melanoma
Announcement as on 20 September 2021
Bristol Myers stock falls toward 6-month low, set to suffer longest losing streak in 3 1/2 years
Shares of Bristol Myers Squibb Co. slumped 1.7% in midday trading Thursday toward a six-month low, putting them on track to suffer the longest losing streak in 3 1/2 years. The stock is headed for a ninth-straight loss, and has declined 7.8% during that s
Announcement as on 16 September 2021
Bristol Myers swings to profit to beat second-quarter estimates as Opdivo returns to growth
Bristol Myers Squibb Co. said Wednesday it swung to a profit of .055 billion, or 47 cents a share, in the second quarter, after a loss of million, or 4 cents a share, in the year-earlier period. Adjusted per-share earnings came to .93, ahead of th
Announcement as on 28 July 2021
Bristol Myers says late-stage trial of head and neck cancer treatment failed to meet main goals
Bristol Myers Squibb Co. said Friday a late-stage study of a treatment for head and neck cancer failed to meet its main goals. The Phase 3 trial sought to compare Opdivo plus Yervoy to the EXTREME regimen (cetuximab, cisplatin/carboplatin and fluorouracil
Announcement as on 16 July 2021
Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |
BMY Bristol-myers Squibb Company current price & indicator signals
Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 23 Thu Jul 2026 | 61.52 | 60.45 to 62.05 | 1.25% | 0.54 times |
| 22 Wed Jul 2026 | 60.76 | 60.56 to 61.70 | -0.28% | 0.99 times |
| 21 Tue Jul 2026 | 60.93 | 59.80 to 61.02 | 1.26% | 1.12 times |
| 20 Mon Jul 2026 | 60.17 | 60.03 to 61.35 | -0.94% | 0.85 times |
| 17 Fri Jul 2026 | 60.74 | 60.41 to 62.29 | 0.38% | 1.15 times |
| 16 Thu Jul 2026 | 60.51 | 58.50 to 60.56 | 3.08% | 0.83 times |
| 15 Wed Jul 2026 | 58.70 | 56.95 to 59.19 | 3.02% | 0.83 times |
| 14 Tue Jul 2026 | 56.98 | 56.78 to 59.46 | -3.98% | 1.11 times |
| 13 Mon Jul 2026 | 59.34 | 57.54 to 59.44 | 3.07% | 1.75 times |
| 10 Fri Jul 2026 | 57.57 | 56.94 to 58.08 | -0.64% | 0.66 times |
| 09 Thu Jul 2026 | 57.94 | 57.14 to 58.00 | 0.71% | 0.71 times |
| 08 Wed Jul 2026 | 57.53 | 57.34 to 58.23 | -0.78% | 0.57 times |
Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


